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ABSTRACT: 28 
Low birth weight (LBW) and premature birth are known risk factors for future cardiovascular 29 
disease and in particular essential hypertension (EH). Capillary rarefaction (CR) is an 30 
established hallmark of EH and is known to occur in individuals with a history of LBW. We 31 
previously reported that LBW infants do not have CR at birth but rather increased capillary 32 
density (CD). We hypothesized that LBW infants undergo a process of accelerated CR in 33 
early life, triggered in part by oxygen therapy. We studied 26 LBW infants, of whom 10 infants 34 
received oxygen therapy, and compared them to 14 normal birth weight (NBW) infants. We 35 
measured CD at 1, 5 and 10 days after birth and again after 40 weeks-adjusted gestational 36 
age equivalent to birth at full term. We confirmed that LBW infants had higher CD at birth 37 
compared to NBW infants and found that significant structural CR occurred at term age in 38 
LBW infants who had received oxygen therapy (mean difference −22 capillaries/field, 39 
p=0.007) and in those who did not receive oxygen therapy (mean difference −29 40 
capillaries/field, p<0.001) compared to baseline at birth. Both LBW groups showed a 41 
significant rise in BP at 40-weeks adjusted term age and the rise in systolic (mean difference 42 
24mmHg, p<0.0001) and diastolic BP (mean difference 14mmHg, p<0.001) was more 43 
pronounced in the oxygen treated group compared to the non-oxygen group (mean difference 44 
14 mmHg, p=0.043 and mean difference= 9 mmHg p=0.056 respectively). In conclusion, 45 
oxygen therapy in premature LBW infants may induce significant increases in their BP in early 46 
life. 47 
 48 
Word count: 250  49 
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INTRODUCTION: 50 
Low birth weight (LBW <2500 grams) is a recognized risk factor for the development of future 51 
essential hypertension (EH), ischaemic heart disease, diabetes mellitus, obesity and 52 
increased cardiovascular mortality in adult life 1,2. The pathophysiological mechanisms are yet 53 
to be elucidated, however, it has been suggested that microcirculatory abnormalities and 54 
impaired tissue perfusion are implicated in the pathogenesis of these cardiovascular disorders 55 
3.  It is thought that the suboptimal in-utero conditions that impair the foetal growth in the first 56 
instance may affect the microvasculature and result in many structural and functional 57 
abnormalities including the reduction in spatial density of capillaries or capillary rarefaction 58 
(CR) 4. We have previously reported that much of the CR in EH is caused by the structural 59 
absence of capillaries 5. We have also shown significant CR in patients with borderline 60 
intermittent EH and in normotensive offspring of hypertensive parents, suggesting a familial 61 
predisposition in which CR represents a primary vascular abnormality that antedates the 62 
onset of sustained elevation of blood pressure (BP) 6,7. We recently reported the unexpected 63 
finding that LBW infants, born at term or preterm to normotensive mothers do not have CR: 64 
instead these infants have a significantly higher dermal CD at birth compared to their normal 65 
birth weight (NBW) counterparts 8. It is becoming increasingly evident that conditions early in 66 
life can influence adult diseases. It has been reported in some studies that hyperoxia during 67 
the neonatal period may have a negative effect on the cardiovascular system 9. We 68 
hypothesized that the high capillary density seen in the LBW infants at birth was an in-utero 69 
compensatory adaptation to unfavourable conditions and that after birth, with the availability 70 
of adequate nutrition and more importantly oxygen, an accelerated capillary remodelling then 71 
ensues 10,11. We set out to test our hypothesis by conducting serial measurements of skin 72 
capillary density in LBW preterm infants receiving oxygen therapy.  73 
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METHODS: 74 
Study subjects:  75 
The study was approved by the London – Riverside Research Ethics Committee 76 
(13/LO/1449) and was conducted at St. George’s University Hospitals NHS Foundation Trust, 77 
London, UK. Written informed consent was obtained from all parents. The infants in the study 78 
were recruited from the Neonatal Intensive Care Unit, Transitional Care Unit and the 79 
Postnatal Ward. We studied 26 LBW infants (<2500 grams, ≥ 30 weeks of gestation) and 14 80 
NBW infants as controls. As this was a pilot pragmatic study, no official power calculation was 81 
done to determine sample size. We excluded infants with sepsis, chromosomal or congenital 82 
abnormalities and those requiring surgery. The antenatal history of the mothers and details of 83 
the findings during the anomaly ultrasound scan were also recorded. Dietary habits, smoking 84 
history, family history of diabetes, ischemic heart disease, stroke, hypercholesterolemia, and 85 
hypertension were obtained from both parents. 86 
Handheld Video Capillaroscopy System (HVCS):  87 
CapiScope Handheld Video Capillaroscopy System (HVCS, KK technology, Devon, England) 88 
was used to measure skin capillary density at the plantar surface of the infant big toe 89 
according to a previously well-validated protocol 8,12,13. The size of the microscopic field was 90 
0.81 mm2, with an image size of 1280 X 1024 pixels and a field view of 1037 x 829 pixels. The 91 
optical illumination of the HVCS device was done using four 525nm light source. The live 92 
images were recorded onto a Panasonic DMR-EX99VEBK HDD recorder.  Disposable sterile 93 
probe covers were used for imaging to minimize the risk of infection. Four microscopic fields, 94 
0.81 mm2 each, were recorded continuously for 30 seconds. The number of all capillaries 95 
(i.e., with stagnant, intermittently flowing and continuously flowing red blood cells) was 96 
counted. Basal capillary density (BCD), which represents functional capillary density, was 97 
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calculated as the mean of these four microscopic fields.  We used venous congestion to 98 
maximize the number of visualized perfused skin capillaries by applying a neonatal BP cuff 99 
(Heine Gamma 7 Sphygmomanometer, Germany) around the calf muscle. The cuff was then 100 
inflated and maintained at 30 mmHg for two minutes, and further images were recorded 101 
continuously for two minutes to determine the maximal capillary density (MCD), which 102 
represents structural capillary density. Capillaries were counted off line using the CapiScope 103 
computer software (KK-Technology, Exeter, UK). Skin temperature was monitored during the 104 
study using an YSI Tele-thermometer (YSI Inc., Dayton, OH, USA).  105 
In LBW infants not requiring oxygen therapy, capillaroscopy was performed immediately after 106 
birth (baseline measurement) provided the cardiorespiratory status was stable and repeat 107 
follow-up measurements were done after 5 days and 10 days. The baseline measurement in 108 
LBW infants requiring oxygen treatment was slightly delayed due to the medical condition of 109 
the infants. In preterm LBW infants an additional measurement of capillary density was taken 110 
at the corrected (i.e. 40 weeks) term age prior to their discharge from hospital or by visiting 111 
them at home. In the NBW group we measured capillary density at birth only before mothers 112 
were discharged from the hospital. Blood and urine samples were obtained from the infants. 113 
Blood Pressure (BP) measurement:  114 
We used the Welch Allyn VSM 300TM series monitor to measure BP in infants at each visit 115 
while they were sleeping or feeding to avoid movement artefacts.  An appropriate sized 116 
disposable Welch Allyn neonatal cuff (size 1 to 4) was used to measure the BP. All 117 
measurements were taken in the lower limb, as this was the easily accessible part to the 118 
neonate inside the incubator.  119 
Proteome Array:  120 
Blood samples were obtained from 13 LBW infants during their stay in the ICU by 121 
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venepuncture or heel prick method. The samples were allowed to clot for 30 minutes and 122 
after centrifugation the serum was aliquoted and stored at -80°C. 201 Cytokines were 123 
measured by Quantibody Human Cytokine Antibody Array 4000 (RayBiotech, Norcross, 124 
Georgia, USA) according to manufacturer’s instructions.  125 
Statistical analysis:  126 
The primary endpoint was the change in maximal (structural) skin capillary density during 127 
venous congestion (MCD) between birth to adjusted age of 40 weeks postnatal life. Shapiro-128 
Wilk test was used to assess the normality of study parameters. ANOVA test with Bonferroni 129 
correction was used for comparison of means among the groups. Student’s t-test was used to 130 
compare the difference of capillary density measurement from baseline to the corrected term 131 
age in the preterm LBW infants. Chi-square test was used to compare proportions between 132 
the LBW and NBW mothers. Pearson correlation coefficient was used to describe the linear 133 
correlation between capillary density and birth weight and changes in BP. Statistical 134 
significance was declared when the p-value was <0.05. All statistical analysis was carried out 135 
using the IBM SPSS 22 (IBM Corporation, Armonk, NY, USA).  136 
 137 
RESULTS: 138 
Table 1 shows the baseline characteristics of study subjects.  There were no significant 139 
differences in maternal age, body mass index, booking BP (i.e. BP measured during the first 140 
antenatal clinic visit), pulsatility index or ultrasound foetal parameters during the anomaly 141 
scan between the groups. Of the 26 LBW infants we studied, 10 received oxygen treatment 142 
either by continuous positive airway pressure, mechanical ventilation or a nasal cannula. 143 
At birth, LBW infants had a significantly higher BCD (mean difference +9.3 cap/field, 95% CI: 144 
1.5 to 17.1, p=0.021) & MCD (mean difference +11.6 cap/field, 95% CI: 1.6 to 21.7, p=0.025) 145 
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compared to the NBW infants. Compared to their NBW counterparts, LBW infants had a 146 
significantly lower diastolic BP (mean difference -10.1mmHg, 95%CI: -17.7 to -2.6, p=0.010). 147 
(Figure) There was no significant difference in systolic BP. Pulse rate was significantly higher 148 
in LBW (mean difference 15.1±10.1 beats/min, 95%CI: 3.4 to 26.8, p=0.013). There was a 149 
significant correlation between birth weight and both BCD (r = -0.309, p=0.052), and MCD in 150 
the entire group (r =-0.355, p=0.025). 151 
At adjusted age of 40 weeks, the LBW oxygen group showed a significant reduction in BCD 152 
(mean difference -20.4 cap/field, 95%CI: -7.2 to -33.6, p=0.009) and MCD (mean difference -153 
20.6 cap/field, 95%CI: -3.7 to -37.5 p=0.025) compared to baseline values at birth. Similarly 154 
the LBW non-oxygen group had a significant reduction in BCD (mean difference -26.7 155 
cap/field, 95%CI -16.3 to -37.1 p<0.0001) and MCD (mean difference -28.2 cap/field, 95%CI, 156 
-17.1 to -39.2 p<0.001). There were no significant differences in BCD and MCD between the 157 
two LBW groups. The reduction in CD was associated with a significant rise in systolic (r=-158 
0.385, p<0.035), and diastolic BP (r=-0.361, p<0.050) in both LBW groups. The rise in systolic 159 
BP and diastolic BP was more pronounced in the LBW oxygen group (mean difference 24 160 
mmHg, 95%CI: 4 to 11, p=0.004 for systolic BP, and mean difference 11mmHg, 95%CI: 3 to 161 
19, p=0.014 for diastolic BP) compared to the LBW non-oxygen group (mean difference 162 
16mmHg, 95%CI: 4 to 6, p=0.005 and mean difference 13mmHg, 95%CI: 3 to 4, p=0.01 163 
respectively). (Table 2)   164 
We found no significant differences in angiogenic or antiangiogenic factors between the two 165 
LBW groups. Macrophage colony stimulating factor was significantly lower in the LBW oxygen 166 
group compared to the LBW non-oxygen group (0.656±0.389 vs 0.217±0.195 pg/ml, p<0.035) 167 
but we are unable to explain the significance of this finding. 168 
 169 
DISCUSSION: 170 
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The study demonstrates that premature LBW infants who received oxygen therapy developed 171 
significant functional and structural capillary rarefaction, which was associated with a 172 
significant increase in both systolic, and diastolic blood pressures at adjusted 40 weeks of 173 
age. We also found that LBW infants who did not receive oxygen therapy developed similar 174 
capillary rarefaction but the increase in their blood pressure was not as significant as in those 175 
who received oxygen therapy. Additionally, we confirmed our previous report that LBW infants 176 
have higher functional and structural capillary densities at birth compared to NBW infants.8 177 
The effect of preterm birth on microvascular development has also been highlighted by 178 
studies showing reduced retinal vascular caliber and density (independently of retinopathy of 179 
prematurity), as well as reduced cutaneous capillary density in children and young adults born 180 
very preterm.14,15 As previously stated, it has become increasingly evident that conditions 181 
early in life can influence adult diseases; but the underlying mechanisms are unkown.16 182 
Recent data suggest that perinatal oxidative stress may be one of the initiating triggers in 183 
long-term programming of cardiovascular function. Our results are in agreement with several 184 
preclinical studies. In animal models, the continuous supplementation of oxygen has been 185 
shown to affect the development of microvasculature and to induce vascular obliteration and 186 
capillary rarefaction17,18 and an increase in blood pressure.19 Yzydorczyk et al, studied 187 
Sprague-Dawley pups who were exposed to 80% oxygen from 3-10 days after birth and found 188 
that in both male and female rats exposed to oxygen as newborns, systolic and diastolic BP 189 
were increased by about 15 mmHg, capillary density was reduced by 30% and the number of 190 
nephrons per kidney was decreased by 25%.9 They suggested that neonatal hyperoxia leads 191 
in the adult rat to increased blood pressure, vascular dysfunction, capillary rarefaction, and 192 
reduced nephron number. It has been shown that the nephron numbers is decreased in adult 193 
individuals with essential hypertension 20 and in intrauterine growth–restricted infants.21,22 194 
Milstein et al studied sublingual microvascular vessel density, vessel diameters, and 195 
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microvascular flow in rabbits breathing sequential oxygen/air mixtures under normobaric and 196 
hyperbaric conditions.19 They found that normobaric hyperoxia produced significant 197 
microvascular rarefaction and significant increases in systolic and mean blood pressure when 198 
compared to normobaric normoxia. Of interest they found that all microcirculatory 199 
abnormalities reverted back to normal values upon return to normoxia. 200 
Ashton et al confirmed that 80% inspired oxygen in healthy kittens caused “vaso-obliteration” 201 
of the newly formed capillaries; when the animals were returned to ambient air, a “vaso-202 
proliferative” effect was observed causing retinopathy of prematurity.23 Oxygen 203 
supplementation in humans during the neonatal period has proven adverse effects on the 204 
microvascular circulation especially in the retina and the lungs.  However it has been shown 205 
previously that capillary density ordinarily decreases after birth in preterm infants who did not 206 
receive oxygen therapy. Kroth et al, measured basal or functional small vessel density 207 
(FSVD) in 25 preterm infants born <30 weeks old using orthogonal polarization spectral 208 
imaging on their upper arm. They found that FSVD decreased at 4 weeks compared to week 209 
1. However, they did not observe any significant change in blood pressure but observed a 210 
negative correlation between FSVD and systolic blood pressure.24 Similarly van Elteren et al, 211 
measured total vascular density (TVD) using incident dark field technology in 60 preterm 212 
infants born less than 32 weeks and 33 term infants during the first month of life. Similar to us, 213 
they found that TVD was higher in preterm infants at birth and that there was a progressive 214 
decline in TVD from birth to 28 days in preterm infants. 25 215 
Our results corroborate with Kistner et al who found that preterm-born women had significant 216 
rarefaction of retinal vessels manifested as fewer numbers of vascular branching points 217 
compared with normal birth weight controls. This was associated with an increased casual 218 
blood pressure suggesting that being born preterm does have effects on the vascular system 219 
that persist into adult life.15 220 
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It has been reported that premature infants have decreased antioxidant defenses and are 221 
exposed upon birth to high oxygen concentration relative to the intrauterine environment.26 222 
Additional oxygen therapy may therefore cause oxidative tissue damage, leading to 223 
pathologies such as retinopathy of prematurity and broncho-pulmonary dysplasia.27 More 224 
recent studies indicate that individuals with a history of premature birth exhibit higher blood 225 
pressure levels and abnormal retinal microvasculature and parameters of cardiovascular 226 
dysfunction. 15,28 While the mechanisms linking prematurity to adult cardiovascular disorders 227 
are unknown, our data and that from others support a putative role for neonatal oxidative 228 
stress. Oxidative stress has been shown to be involved in the promotion of rarefaction 229 
through endothelial apoptosis in hypertensive rats, while treatment with antioxidants has 230 
resulted in a reduction of microvessel loss.29  231 
We acknowledge the limitations in our study that include the small numbers of LBW infants 232 
treated with oxygen, but this highlights the difficulties in recruiting such infants while they are 233 
in the neonatal intensive care unit (NICU). There was also uneven ethnicity and the significant 234 
difference in the age of infants on the study day may have been a confounding factor.30 235 
However, we assessed BCD and MCD in NBW term infants of different ethnic backgrounds 236 
born to normotensive mothers and found no difference in capillary density between the 237 
different groups (unpublished data). There was also significant variability in the mode of 238 
oxygen therapy, duration and percentage of fractional percentage of inspired oxygen (FiO2) 239 
received in the post-natal period. It was not possible to control for the above factors, or render 240 
them uniform for the study, as they were tailored according to the clinical needs of each 241 
preterm infant. The timing of baseline measurement in the LBW oxygen group was slightly 242 
delayed compared to the non-oxygen group because of limited access to the NICU due to the 243 
medical condition of the baby. However, the mean gestational age was closely matched 244 
during the serial measurement of capillary density between the groups. All the blood samples 245 
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were taken within the first two weeks in the NICU as we aimed for the blood sampling to 246 
coincide with routine clinical blood sampling to avoid additional discomfort to the baby. 247 
Similarly, blood pressure measurements were taken only once, again to avoid undue 248 
discomfort to the infants. We have previously observed that sequential BP measurements 249 
awaken infants and disturb them, such that second and third readings were almost always 250 
higher than the first reading. We therefore ensured that all the BP measurements were taken 251 
while the baby was sleeping or feeding to minimise any artefacts.  252 
In conclusion, oxygen therapy in premature LBW infants in the neonatal period is associated 253 
with higher systolic and diastolic BP levels but has no significant effect on the rate of capillary 254 
reduction from birth to adjusted age of 40-weeks. Further studies are needed to investigate 255 
the humoral factors that trigger the microcirculatory changes in LBW infants during the 256 
neonatal period, which will be of importance in preventing future hypertension and 257 
cardiovascular diseases in later life.    258 
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Figure Legend: 341 
Changes in the capillary density (A & B), systolic blood pressure (C & D) and diastolic blood 342 
pressure (E & F) from baseline measurement to adjusted 40 weeks of age in preterm LBW 343 
infants. Both the LBW oxygen group and the LBW control group showed a statistically 344 
significant reduction in the capillary density (A&B) followed by increase in the blood pressure 345 
(C-F).  346 
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Table 1: Baseline Characteristics of Study Subjects  347 
 
Variables 
LBW Oxygen 
(n= 10) 
LBW Non-
oxygen 
(n=16) 
NBW Control 
(n=14) 
P- value 
ANOVA 
Maternal Data:    
Age (years) 34±2.0 34±7.8 31±4.0 0.198 
BMI (kg/m2) 27.0±6.8 30.2±6.3 28.2±5.4 0.447 
Blood Pressure (mmHg)     
Systolic  123±14 125±13 114±17 0.161 
Diastolic  77±14 77±16 72±7 0.614 
Ethnicity n(%)     
Caucasian 4 (40) 9 (56.3) 7 (50) 1.0 
South Asian 2 (20) 4 (25) 5 (35.8) 1.0 
Afro Caribbean 2 (20) 3 (18.7) 1 (7.1) 1.0 
Mixed  2 (20) 0 1 (7.1) 1.0 
HDP  5 (50) 6 (37.5) 1 (7.1) 0.059 
Family history of HTN  3 (30) 8 (50) 10 (71.4) 0.324 
    
Prenatal Data:    
Bi-Parietal diameter (cm) 54.2±3.8 52.3±2.4 53.2±2.4 0.258 
Head circumference (cm) 182.5±25.9 186.8±7.3 178.8±43.2 0.780 
Femur length (cm) 34.7±3.3 35.3±1.4 36.2±1.5 0.227 
Abdominal Circumference (cm) 161.5±14.2 162.4±8.6 167.2±11.0 0.409 
Uterine artery PI  2.79±0.89 2.53±0.74 2.42±0.56 0.640 
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Neonatal Data:     
Birth weight (grams) 1645±418 1715±377 3388±558 0.0001 
Gestational age (weeks) 32.5±1.4 33.3±1.7 39.1±2.29 0.0001 
Age at Capillaroscopy (days) 9±6 4±4 2±1 0.001 
Gestational age at analysis 33.8±1.7 34.0±1.6 39.3±2.1 0.0001 
Weight on study day (grams) 1513±299 1740±331 3388±588 0.0001 
Capillary Density (per mm2)     
Basal  92±15 93±18 83±8 0.155 
Maximal  97±17 101±17 87±11 0.069 
Skin Temperature °C 34.8±1.5 34.9±1.2 33.7±1.2 0.106 
Room Temperature°C 24.6±0.97 25.2±1.5 26.7±1.2 0.001 
Blood Pressure (mmHg)     
Systolic  61±9 68±13 70±11 0.168 
Diastolic  33±6 38±10 45±12 0.022 
Mean 43±8 48±10 53±11 0.104 
Heart Rate 145±15 131±17 122±14 0.007 
     
Laboratory results:     
Haemoglobin 147±20 180±26 171±21 0.022 
Haematocrit 46±6.3 55±8.4 56±0.1 0.035 
Bilirubin 143±70 156±40 123±1.4 0.803 
pO2 6.7±1.5 6.4±1.5 NA 0.827 
pCO2 6.3±0.9 5.9±0.8 NA 0.166 
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Duration of O2 exposure 
(Hours) 
347.8±524.8    
Maximum FiO2 given  59.6±34.2    
 348 
LBW=low birth weight, NBW=normal birth weight, HDP=hypertensive disorder of pregnancy, 349 
FiO2 = Fractional percentage of inspired oxygen.   350 
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Table 2. Comparison between LBW babies at adjusted 40th week who were treated or 351 
not treated with oxygen compared to NBW infants at term  352 
Variables LBW 
Oxygen  
(n= 10) 
(40th week) 
LBW non-
oxygen 
(n=16) 
(40th week) 
NBW 
Control 
(n=14) 
(Term age) 
P- value 
ANOVA 
Capillary Density (per mm2)     
Basal  69±12 66±11 83±8 0.0001 
Maximal  72±11 72±9 87±11 0.005 
Blood Pressure (mmHg)     
Systolic  85±9 81±10 70±11 0.006 
Diastolic  49±7 47±8 45±12 0.742 
Heart Rate 160±11 158±14 122±14 0.0001 
LBW=low birth weight, NBW=normal birth weight   353 
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Summary Table: 354 
“What is known about topic:” 355 
• Low birth weight and premature birth are known risk factors for future cardiovascular 356 
disease and in particular essential hypertension  357 
• Capillary rarefaction is an established hallmark of essential hypertension and is known 358 
to occur in individuals with a history of low birth weight 359 
• It has been shown recently that low birth weight infants do not have capillary 360 
rarefaction at birth, but rather increased capillary density compared to normal birth 361 
weight 362 
• In preclinical animal studies, oxygen therapy has been shown to induce vascular 363 
obliteration and capillary rarefaction in the new born 364 
“What this study adds”: 365 
• Oxygen therapy in premature low birth weight infants in the neonatal period is 366 
associated with higher systolic and diastolic blood pressure levels but has no 367 
significant effect on the rate of capillary reduction  368 
• Further studies are needed to investigate the humoral factors that trigger the 369 
microcirculatory changes in low birth weight infants during the neonatal period, which 370 
will be of importance in preventing future hypertension and cardiovascular diseases in 371 
later life 372 
        A                 B 
 
        C                                                               D 
    
         E                                                                  F 
  
 
 
